Health Information Management

Q&A: CMS adds new drugs to pass-through status list with OPPS update

APCs Insider, October 3, 2014

Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

Q: Where can I find out more about new drugs or biologicals with pass-through status beginning in October?
 
A: Four drugs and biologicals are eligible for pass-through payments as of October 1, 2014, according to Transmittal 3012. All four HCPCS codes are new and listed in Table 2 of the transmittal:
  • C9023, injection,  testosterone undecanoate, 1 mg
  • C9025, injection, ramucirumab, 5 mg
  • C9026, injection, vedolizumab, 1 mg
  • C9135, Factor IX (antihemophilic factor, recombinant), Alprolix, per 10 i.u.
Each has been assigned to status indicator G (pass-through drugs and biologicals) and will receive payments based on APC 1487, 1488, 1489, and 1486 respectively. 
In addition, CMS established the following two additional HCPCS codes for epoetin beta, both of which became effective October 1:
  • Q9972, injection, epoetin beta, 1 microgram (for end-stage renal disease [ESRD] on dialysis)
  • Q9973, injection epoetin beta, 1 microgram (non-ESRD use)
The transmittal notes these are for reporting in the hospital outpatient setting. However, both codes are assigned to status indicator E (codes not paid under the OPPS when submitted on any outpatient bill type).
 
These codes are listed in Table 3 of the transmittal.
 
Editor’s note: Denise Williams, RN, CPC-H, seniorvice president of revenue integrity services at Health Revenue Assurance Associates, Inc., in Plantation, Florida, answered this question.



Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

    Briefings on APCs
  • Briefings on APCs

    Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...

  • HIM Briefings

    Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...

  • Briefings on Coding Compliance Strategies

    Submitting improper Medicare documentation can lead to denial of fees, payback, fines, and increased diligence from payers...

  • Briefings on HIPAA

    How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...

  • APCs Insider

    This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...

Most Popular